TYRA
Price:
$26.99
Market Cap:
$1.61B
Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, desi...[Read more]
Industry
Biotechnology
IPO Date
2021-09-15
Stock Exchange
NASDAQ
Ticker
TYRA
According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.53B. This represents a change of 21.17% compared to the average of 1.26B of the last 4 quarters.
The mean historical Enterprise Value of Tyra Biosciences, Inc. over the last ten years is 756.23M. The current 1.53B Enterprise Value has changed 20.08% with respect to the historical average. Over the past ten years (40 quarters), TYRA's Enterprise Value was at its highest in in the March 2026 quarter at 2.29B. The Enterprise Value was at its lowest in in the September 2021 quarter at -150456187.23.
Average
756.23M
Median
709.58M
Minimum
69.73M
Maximum
1.50B
Discovering the peaks and valleys of Tyra Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 674.37%
Maximum Annual Enterprise Value = 1.50B
Minimum Annual Increase = -75.28%
Minimum Annual Enterprise Value = 69.73M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.50B | 110.74% |
| 2024 | 709.58M | 31.42% |
| 2023 | 539.94M | 674.37% |
| 2022 | 69.73M | -75.28% |
| 2021 | 282.08M | -74.14% |
| 2020 | 1.09B | -1.38% |
The current Enterprise Value of Tyra Biosciences, Inc. (TYRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
914.96M
5-year avg
619.34M
10-year avg
756.23M
Tyra Biosciences, Inc.’s Enterprise Value is greater than Rezolute, Inc. (375.04M), greater than Savara Inc. (1.07B), greater than Geron Corporation (918.81M), greater than Prime Medicine, Inc. (551.62M), less than Day One Biopharmaceuticals, Inc. (2.03B), greater than Kura Oncology, Inc. (788.60M), less than Maravai LifeSciences Holdings, Inc. (2.49B), less than Nanobiotix S.A. (1.60B), greater than ProKidney Corp. (1.15B), greater than EyePoint Pharmaceuticals, Inc. (1.03B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 375.04M | $385.17M | |
| 1.07B | $1.08B | |
| 918.81M | $737.75M | |
| 551.62M | $501.21M | |
| 2.03B | $2.22B | |
| 788.60M | $803.41M | |
| 2.49B | $1.38B | |
| 1.60B | $1.80B | |
| 1.15B | $551.46M | |
| 1.03B | $1.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tyra Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tyra Biosciences, Inc. (TYRA)?
What is the 3-year average Enterprise Value for Tyra Biosciences, Inc. (TYRA)?
What is the 5-year average Enterprise Value for Tyra Biosciences, Inc. (TYRA)?
How does the current Enterprise Value for Tyra Biosciences, Inc. (TYRA) compare to its historical average?